Figs Inc is a company that specializes in designing and producing high-quality, stylish scrubs and medical apparel for healthcare professionals. With a focus on comfort, functionality, and modern aesthetics, Figs aims to revolutionize the way medical uniforms are perceived and worn. The company leverages innovative fabrics and inclusive sizing to cater to the diverse needs of its customers, ultimately enhancing the work experience for those in the medical field. In addition to scrubs, Figs also offers various accessories and lifestyle products tailored for healthcare workers, fostering a sense of community and pride among its clientele. Read More
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Hanesbrands (NYSE:HBI) and the rest of the apparel and accessories stocks fared in Q2.
Noah Wyle, star of medical drama The Pitt and Emmy nominee at the 77th Emmy Awards, is making fashion history on the red carpet wearing the first-ever tuxedo designed by a scrubwear company. The custom creation by healthcare apparel company, FIGS, merges television’s biggest stage with a deeply meaningful and personal tribute to healthcare workers.
Shares of healthcare apparel company Figs (NYSE:FIGS)
fell 3.2% in the morning session after investors appeared to take some profits following a recent rally, coupled with broader concerns about a potential slowdown in consumer spending. The decline follows a strong performance for the medical apparel company, which saw its stock price gain over 7% in the previous trading session and hit a 52-week high of $7.31.
Looking back on apparel and accessories stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Figs (NYSE:FIGS) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Levi's (NYSE:LEVI) and its peers.
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the apparel and accessories industry, including Movado (NYSE:MOV) and its peers.
A number of stocks jumped in the afternoon session after the latest Consumer Price Index (CPI) report came in largely as expected, reinforcing investor hopes for an upcoming Federal Reserve interest rate cut.
Expensive stocks often command premium valuations because the market thinks their business models are exceptional.
However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.
A number of stocks fell in the afternoon session after the major indices continued to retreat (Nasdaq -1.5%, S&P 500 -1.2%) amid profit-taking and renewed concerns about tariffs.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief Financial Officer, are scheduled to participate in a fireside chat at the Goldman Sachs 32nd Annual Global Retailing Conference on Wednesday, September 3, 2025, at 3:55 p.m. ET.
A number of stocks fell in the morning session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell.
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
A number of stocks jumped in the afternoon session after the latest Consumer Price Index (CPI) report showed inflation holding steady, bolstering investor optimism for a potential interest rate cut by the Federal Reserve. The data, which revealed that inflation remained at 2.7% for the year ending in July, was seen as a positive sign by investors. This stability increases the likelihood that the Federal Reserve might lower interest rates at its upcoming September meeting. Lower interest rates can stimulate the economy by making borrowing cheaper for both consumers and businesses, which often translates into higher consumer spending. This is particularly beneficial for the Consumer Discretionary sector, which includes companies selling non-essential goods and services like apparel, travel, and electronics.
Healthcare apparel company Figs (NYSE:FIGS) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 5.8% year on year to $152.6 million. Its non-GAAP profit of $0.04 per share was $0.02 above analysts’ consensus estimates.
Healthcare apparel company Figs (NYSE:FIGS) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.8% year on year to $152.6 million. Its GAAP profit of $0.04 per share was $0.03 above analysts’ consensus estimates.
FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its second quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments.
Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
The stocks featured in this article are seeing some big returns.
Over the past month, they’ve outpaced the market due to new product launches, positive news, or even a dedicated social media following.
Shares of healthcare apparel company Figs (NYSE:FIGS)
fell 3.4% in the pre-market session after investors reacted to a cautious outlook from Wall Street analysts, which included a "Sell" rating from Goldman Sachs.
